INFUSION Services
Renown Infusion Services provides outpatient treatment to adults 16 years of age and older. We are open 365 days a year, with 25 patient treatment areas including 3 private rooms and 21 interactive treatment bays with Wi-Fi access and a personal television. Our on-site pharmacy and laboratory is staffed with pharmacists and a lab technician, who work alongside the oncology certified nurses enabling us to provide comprehensive care to you.
In winter 2016, construction will begin in the Institute for Cancer to expand our Infusion Services, adding four additional treatment bays to meet the needs of our growing community.
We treat a variety of diagnoses including, but not limited to, cancer, multiple sclerosis, anemia, osteoporosis, osteomyelitis, rheumatoid arthritis and genetic disorders. We offer precision treatments such as clinical trials, and the latest immunotherapy and chemotherapy drugs. Our nurses work in collaboration with your healthcare team to ensure quality care. They perform therapeutic phlebotomies, administer IV medications, give injections and administer blood and platelet transfusions. The nurses also perform lab draws, central line care and provide education about specific treatments.
INPATIENT Care
Brandi Griggs, RN, BSN, OCN Manager, Infusion Services
Inpatient Cancer Care has 27 private rooms specializing in the care of all types of cancer. All of our nursing staff earn competency to administer chemotherapy and biotherapy via national certificate( Oncology Nursing Society / Oncology Nursing Certification Corporation) or internally via Renown’ s Chemotherapy and Biotherapy Certificate Course. Instruction in these courses is rigorous, and provides training in the administration of Chemotherapy and Biotherapy agents along with symptom management, safe handling, and psychosocial dimensions of care.
One of the most serious side effects from chemotherapy is known as Febrile Neutropenia, a condition of having an unusually low number of cells called neutropils and a fever of 100.4 degrees Fahrenheit or greater. Renown developed a febrile Neutropenia Protocol in 2016 which allows clinicians to identify cancer patients at risk for this life threatening side effect quickly. Once identified, these patients are immediately moved into a prescribed antibiotic therapy protocol. By following this protocol, we have improved positive response outcomes and our patient’ s experience. Our high risk patients with Neutropenia are provided alert cards. Patients can present these cards to any ER employee and receive the expedited care of the Neutropenia protocol.
9